BeyondSpring Inc. Other Expenses
BeyondSpring Inc. (BYSI) reported Other Expenses of $242.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OtherExpenses · last filed 2026-08-14
- BeyondSpring Inc. other expenses for the quarter ending 2026-06-30 was $242.00K, a 29.03% decline year-over-year.
- BeyondSpring Inc. other expenses for the quarter ending 2026-03-31 was $256.00K, a 10.18% decline year-over-year.
- BeyondSpring Inc. other expenses for the quarter ending 2025-12-31 was $446.00K, a 28.90% increase year-over-year.
- BeyondSpring Inc. other expenses for the quarter ending 2025-09-30 was $314.00K, a 16.73% increase year-over-year.
- BeyondSpring Inc. other expenses for fiscal 2025 was $1.37M, a 6.95% increase from fiscal 2024.
- BeyondSpring Inc. other expenses for fiscal 2024 was $1.28M, a 50.31% decline from fiscal 2023.
- BeyondSpring Inc. other expenses for fiscal 2023 was $2.58M.
| Period end | Other Expenses 3 month | Other Expenses 6 month | Other Expenses 9 month | Other Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $242.00K 10-Q · filed 2026-08-14 | $499.00K 10-Q · filed 2026-08-14 | $944.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.26M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $256.00K 10-Q · filed 2026-05-13 | $702.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.02M derived: sum of 3 quarters · filed 2026-05-13 | $1.36M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $760.00K derived: sum of 2 quarters · filed 2026-03-25 | $1.10M derived: sum of 3 quarters · filed 2026-08-14 | $1.37M 10-K · filed 2026-03-25 |
| 2025-09-30 | $314.00K 10-Q · filed 2025-11-12 | $655.00K derived: sum of 2 quarters · filed 2026-08-14 | $923.00K 10-Q · filed 2025-11-12 | $1.29M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $341.00K 10-Q · filed 2026-08-14 | $610.00K 10-Q · filed 2026-08-14 | $972.00K derived: sum of 3 quarters · filed 2026-08-14 | $1.24M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $285.00K 10-Q · filed 2026-05-13 | $631.00K derived: sum of 2 quarters · filed 2026-05-13 | $900.00K derived: sum of 3 quarters · filed 2026-05-13 | $1.20M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $346.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $615.00K derived: sum of 2 quarters · filed 2026-03-25 | $911.00K derived: sum of 3 quarters · filed 2026-03-25 | $1.28M 10-K · filed 2026-03-25 |
| 2024-09-30 | $269.00K 10-Q · filed 2025-11-12 | $565.00K derived: sum of 2 quarters · filed 2025-11-12 | $934.00K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $296.00K 10-Q · filed 2025-08-13 | $663.00K 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | $363.00K 10-Q · filed 2025-05-12 | |||
| 2023-12-31 | $2.58M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |